EQRx Revises Plans To Get Chinese Licensed Drugs To US Market

 
• By Jessica Merrill
  
U turn
EQRx is changing development plans for two drugs licensed from Chinese partners. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D